Clarametyx Biosciences, Inc.
- Ted Torphy
Ted Torphy, Ph.D. has accumulated over 30 years of experience in the pharmaceutical industry with a successful record in both small-molecule and large-molecule drug discovery and preclinical development. Previously, he served as CSO and CEO for BioMotiv, after spending 12 years with Johnson & Johnson Pharmaceuticals, including four years at the biopharmaceutical arm of Johnson & Johnson. Prior, Dr. Torphy spent 17 years with SmithKline Beecham, most recently as Vice President and Head of Biological Research for the cardiovascular, pulmonary, renal, metabolic diseases, and inflammation therapeutic areas. He has authored more than 120 journal articles, review articles, book chapters, and patents, and served on the editorial boards of numerous scientific journals.